Literature DB >> 26003065

A millennial view of cystic fibrosis.

John A Dodge1.   

Abstract

Although only identified as a distinct disease in the 1930s, it was soon apparent that Cystic Fibrosis (CF) had been present, but unrecognised, in European populations for many years - perhaps even centuries [1] . Within a decade of the early descriptions, the autosomal recessive nature of this genetic disease had been clarified, and its clinical features had been expanded. Secondary nutritional deficiencies complicated the underlying condition: the first clear description of CF as "a new disease", which included a speculation about its genetic basis (because there were 2 pairs of sibs in the case series) was published as Vitamin A deficiency in children [2]. The diagnosis was most often made at autopsy. When it was suspected in life, the diagnostic tests used included duodenal intubation to obtain fluid which would show impaired tryptic digestion of the coating of X-Ray film in CF children, and measurement of vitamin A in the blood. Some nutritional improvement could be expected with simple, rather inefficient pancreatic enzyme preparations, but it was not until mid-century that antibiotics began to treat pulmonary infections effectively. As a young doctor in the 1950s I soon became aware that the median age at death for affected children was about one year, and most died before reaching school age. .

Entities:  

Mesh:

Year:  2015        PMID: 26003065

Source DB:  PubMed          Journal:  Dev Period Med


  5 in total

1.  Outstanding contribution of British medicine to child health in Sudan.

Authors:  Mustafa Abdalla M Salih; Mohammed Osman Swar
Journal:  Sudan J Paediatr       Date:  2016

2.  Treatment of high-grade osteoblastic osteosarcoma of the humerus in a 5-year-old boy with cystic fibrosis: A case report.

Authors:  Kenichi V Okuda; Jutta Hammermann; Björn S Lange; Jana C Fischer; Falk Thielemann; Ralf Knöfler; Meinolf Suttorp
Journal:  Mol Clin Oncol       Date:  2017-05-29

3.  Early diagnosis effects the prognosis in children with atypical wheeze.

Authors:  Ezgi Ulusoy Severcan; Esen Demir; Figen Gülen; Raziye Burcu Güven Bilgin; Remziye Tanaç
Journal:  Turk Pediatri Ars       Date:  2020-09-23

Review 4.  Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data.

Authors:  Pieter-Jan De Sutter; Maxime Van Haeverbeke; Eva Van Braeckel; Stephanie Van Biervliet; Jan Van Bocxlaer; An Vermeulen; Elke Gasthuys
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-06-29

Review 5.  Research advances in molecular mechanisms underlying the pathogenesis of cystic fibrosis: From technical improvement to clinical applications (Review).

Authors:  Tao Wei; Hongshu Sui; Yanping Su; Wanjing Cheng; Yunhua Liu; Zilin He; Qingchao Ji; Changlong Xu
Journal:  Mol Med Rep       Date:  2020-10-16       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.